Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression.
about
The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosisVascular comorbidity is associated with more rapid disability progression in multiple sclerosisThe expanding genetic overlap between multiple sclerosis and type I diabetesSystematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosisTreatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effectsUnderstanding Drivers of Employment Changes in a Multiple Sclerosis Population.Smoking status over two years in patients with multiple sclerosis.Fall risk in people with MS: A Physiological Profile Assessment study.Impact of a 5-day expedition to machu picchu on persons with multiple sclerosis.Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis.Patient perspectives on switching disease-modifying therapies in the NARCOMS registry.Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international surveyA high-density screen for linkage in multiple sclerosis.Escalating immunotherapy of multiple sclerosis.Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis.Can meditation influence quality of life, depression, and disease outcome in multiple sclerosis? Findings from a large international web-based studyValidation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosisThe role of exercise in modifying outcomes for people with multiple sclerosis: a randomized trial.A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis.Glucose uptake heterogeneity of the leg muscles is similar between patients with multiple sclerosis and healthy controls during walking.Clinically significant fatigue: prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internetLower urinary tract symptom prevalence and management among patients with multiple sclerosisCost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based study.One year changes in disability in multiple sclerosis: neurological examination compared with patient self reportThe association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis.Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disabilityDeveloping a Valuation Function for the Preference-Based Multiple Sclerosis Index: Comparison of Standard Gamble and Rating Scale.Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study.Weight status in persons with multiple sclerosis: implications for mobility outcomes.Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal studyThe effects of prolonged wear of textured shoe insoles on gait, foot sensation and proprioception in people with multiple sclerosis: study protocol for a randomised controlled trial.Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics.Disability in multiple sclerosis: a reference for patients and clinicians.An Exploratory Investigation of Social Stigma and Concealment in Patients with Multiple SclerosisMapping the 12-item multiple sclerosis walking scale to the EuroQol 5-dimension index measure in North American multiple sclerosis patients.Cumulative impact of comorbidity on quality of life in MS.Health insurance affects the use of disease-modifying therapy in multiple sclerosis.Comorbidity delays diagnosis and increases disability at diagnosis in MS.Association of fish consumption and Ω 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis.
P2860
Q21245612-18EA153E-BA19-49C8-8FEB-DF770CF71E22Q24607442-82C4B300-1EBC-4634-A66A-82D4B184E158Q24642348-892C9024-A8BE-432A-A95F-484784DB6A7EQ27004079-E7B40383-2710-40CE-9224-EB105580C2BDQ28216546-4C8C8660-E00A-41A2-A462-FA5286792F72Q30667407-1D635423-C550-48B7-AE94-9D2C7A5390A6Q33668818-75927DCD-61B0-4A6E-8B62-6E46D9EC3B1DQ33693103-EC0F75E7-BA40-4436-8955-3A4BA43B21B3Q33747494-58AA251F-D0BF-4D54-BFC7-4EC763461E16Q33825885-F134F1BE-E0AE-46F5-9EA2-54886305F1B6Q33890415-B0568691-ADAD-47DB-9ECB-FD56238E10D7Q33949816-956E5238-9154-4ACA-A2E9-A22CCBCB9C66Q34021149-B66F39C3-3F50-4721-B44B-78B6049E74F2Q34409100-50C5D823-7ADA-4767-A8D5-BEA2939DE056Q34409273-43821696-2084-430A-B075-8EEA849CB1F7Q34565142-8EF83813-78AA-4772-ABE4-DFCDE0091364Q34575351-10FC4A0A-EEB3-4E6D-A117-345F1B92AFD0Q34687024-1D3B4016-6FF8-41C8-9009-69E052D0D75AQ34786548-7EF6BC20-3179-4429-BC0F-312F9684CC12Q34982072-CCB905A0-9FE1-4814-83BD-46AB908F897DQ35070023-DA405BA4-2BA4-4D89-B685-80EC50DF2F10Q35097889-16EC0AE8-A56C-42F5-B846-0669F5F49B73Q35114665-16C54280-01EA-4EA1-87C2-09C2E3772CF0Q35119597-D64D48E9-F9FB-43CD-9A5D-63EB31FDF756Q35472473-45C5D057-E4AF-4CD7-AD19-45118BBEAA10Q35798769-C694C445-0105-42DA-8AA8-4E26047193CFQ35866381-A04A421E-E99E-4AFF-96C8-C3ECABD1196DQ36001702-30831AE2-8EF5-4891-BB3F-BA867F2615E7Q36112918-F318C844-4EDA-433D-BA6A-F57CC78FF8ECQ36294203-203E7D9D-0198-47C0-BED8-92885EF93E9AQ36526965-9AE989EA-EAC1-44DE-87E3-3739E94D1832Q36820541-F0B33EBD-C0D5-48E9-86CE-33156D7D36DEQ36830898-A71D115D-922B-4AE1-B789-E7C6295A4240Q36841485-EBF8BBEE-8308-4D5C-905B-5F71F1AF702AQ36848175-505DB23F-CB01-4C62-BF8C-8FA16B94C033Q36876562-3CB07C45-9750-43AC-B33E-1C977E14B75FQ37109732-6F9D07B9-7DFB-4F5C-B6D0-D07E7AF2EF52Q37158954-C4EA6046-0994-4C6B-9ACC-9C0F4854B24EQ37180451-909249A8-2A7F-4B5C-971F-CB98C53523D2Q37290620-0138FEC1-6FDA-491D-AB02-77EF4E096A12
P2860
Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Disease steps in multiple scle ...... evaluate disease progression.
@en
type
label
Disease steps in multiple scle ...... evaluate disease progression.
@en
prefLabel
Disease steps in multiple scle ...... evaluate disease progression.
@en
P2093
P1476
Disease steps in multiple scle ...... evaluate disease progression.
@en
P2093
P304
P356
10.1191/135245899678846375
P577
1999-10-01T00:00:00Z